Medication info
Freetwin Tablet 80/5 mg

Freetwin Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Dongkook Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double-coated tablet in white and light gray
Packaging
30 tablets/box [(10 tablets/PTP*3)]
Approval status
Active

MFDS item code 201605802 · Approved 2016.09.30 · Insurance code 653403720

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Dongkook Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control the blood pressure of patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can pose serious risks to the fetus during pregnancy, particularly in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. People with allergies to this drug's main ingredients or similar components, those with biliary obstruction diseases, severe liver impairment, heart problems, etc., should not take this medication. Patients with decreased kidney function or diabetes, as well as nursing mothers, are also advised not to use this medication. Careful use is required for patients with certain heart valve diseases, liver impairment, gastrointestinal diseases, renal artery hypertension, and in the elderly, and caution is needed when used in combination with other blood pressure medications. The most common side effects of this medication include dizziness and swelling in the hands and feet; rarely, fainting or cardiac issues may occur. This medication should not be used during pregnancy, and if pregnancy is confirmed, treatment should be discontinued immediately and switched to a safe alternative. Caution is required when there is a lack of fluids or salt, as low blood pressure may occur; if blood pressure drops too low, appropriate treatment should be sought. Since there is a risk of increased potassium levels in the blood, caution is advised when taking potassium supplements or medications high in potassium. Patients with impaired kidney function should have regular blood tests to monitor kidney function and electrolyte levels. Patients with heart disease or heart failure may see their symptoms worsen while taking this medication. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Diabetics may have an increased risk of cardiovascular diseases while taking this medication, so regular cardiac examinations and evaluations are recommended. Dizziness or drowsiness may occur during treatment, so caution is advised when driving or operating machinery. This medication may interact with other drugs, so especially when taken with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc., consultation with a physician or pharmacist is necessary. In the case of overdose, symptoms like low blood pressure, dizziness, or cardiac arrhythmias may appear, and it is important to seek immediate medical attention for appropriate treatment. Safety and efficacy in children have not been sufficiently established, so it is not recommended for them, and dosing in the elderly should start at a lower dose and increase gradually.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver disorder
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin pigmentation
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitive reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • increased frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased serum creatine phosphokinase
  • reduced hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a light- and air-protected, sealed container, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Biconvex oval double-coated tablet in white and light gray

Package unit

30 tablets/box [(10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.